Sanny Bagulwar co-founded Cleanstep Pharma & Engineering Solutions in October 2020, focusing on validation and consulting services within the pharmaceutical and engineering sectors.
Prior to the establishment of Cleanstep, Sanny worked as a Validation Specialist at Pfizer from March 2015 until October 2020, contributing to the development and quality assurance of pharmaceutical products.
Sanny's experience includes a role as a Senior Officer at Wockhardt Ltd. from February 2011 to March 2015, where responsibilities likely involved ensuring product compliance and quality standards.
Before Wockhardt, Sanny served as an Officer at Veco Labs starting in November 2009, building foundational skills in laboratory operations and compliance.
Sanny began the professional journey as an Officer at Indoco Remedies Ltd. in June 2008, gaining essential experience in the pharmaceutical field.
Through various roles in prominent organizations, Sanny accumulated significant expertise in validation processes, contributing to enhanced product integrity and safety in the pharmaceutical industry.
Cleanstep Pharma & Engineering Solutions is marked by a commitment to innovative solutions and high standards in validation practices, reflecting Sanny's dedication to quality and compliance.
As co-founder, Sanny has likely faced the challenges of establishing a new business in a competitive market, demonstrating resilience and strategic leadership skills.
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Cleanstep Pharma & Engineering Solutions (Validation/Consulting) corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Sanny Bagulwar's net worth? Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them? Through Cleanstep Pharma & Engineering Solutions (Validation/Consulting)'s official communication channels.
Is this an official profile? No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible
information and independent research. While accuracy is prioritized, content may not always reflect the
latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured
has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication
channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)